HomeProductsBuilding BlocksHeterocyclic ScaffoldsAliphatic HeterocyclesDeflazacort
Chemical structure of CAS 14484-47-0

Deflazacort

CAS No.14484-47-0
MDL No.MFCD00866106
MFC25H31NO6
MW441.50
InChI KeyFBHSPRKOSMHSIF-GRMWVWQJSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Deflazacort is a corticosteroid hormone.

CAS No.14484-47-0
Product NameDeflazacort

Biological Targets

NR3C1

Associated Conditions

muscular dystrophy·liver disease·limb-girdle muscular dystrophy·neuromuscular disease caused by qualitative or quantitative defects of dysferlin·kidney disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

[Pharmacokinetics of deflazacort tablets in healthy Chinese volunteers].

Yao xue xue bao = Acta pharmaceutica Sinica • Vol. 49, Issue 6 • 2014
PMID: 25212041

The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology • Vol. 31, Issue 1 • 2012
PMID: 22655512PMC: PMC3440807

Deflazacort.

Journal of postgraduate medicine • Vol. 55, Issue 4 • 2009
PMID: 20083885DOI: 10.4103/0022-3859.58942

Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up.

Pediatric neurology • Vol. 38, Issue 3 • 2008
PMID: 18279756DOI: 10.1016/j.pediatrneurol.2007.11.001

Documentation

Similar Products